On 2 Dec 2020, The United Nations Commission on Narcotic Drugs (CND) accepted a World Health Organization (WHO) recommendation to remove cannabis and cannabis resin from Schedule IV of the 1961 Single Convention on Narcotic Drugs by votes.

In recent years, well-controlled clinical trials have identified therapeutic uses for certain isolated cannabinoids, most notably the product Epidiolex, which contains highly purified cannabidiol extracted from the cannabis plant and which was approved by the U.S. Food and Drug Administration in 2018 for the treatment of two rare seizure disorders in children. As a result, the legitimate medical use of cannabis preparation has been established through scientific research, and cannabis no longer meets the criterion for placement in Schedule IV of the Single Convention. And with the removal of cannabis from Schedule IV of the 1961 Single Convention, the medicinal usefulness of cannabis can no longer be denied.

While United States and the majority have voted ‘yes’ to this amendment, it is disappointing that so called People’s Republic of China voted ‘no’ and joined the alliance of Russia despite of numerous papers and clinical trials showing the therapeutic and medical benefits of cannabis.

Obviously, many countries have a different standard in human rights, and they pretend blind against countless evidence of cannabis makes so helpful for the human life and the world for the sake of their own ‘system’ preservation instead of the people using the ‘system’.

While the Beijing voice of People’s Republic of China vote no, can HKSAR voice a different perspective of medical cannabis?

Dear Carrie Lam, would you introduce HKSAR a different system which acknowledge the medical use of cannabis? One country Two system? Does it ring any bells?